Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia
2021 Update on HER2+ MBC: Neratinib/Cape vs. Lapatinib/Cape in MBC, New Oral Pan-HER TKIs, T-DXd, Trastuzumab Duocarmazine, Patritumab Deruxtecan, Margetuximab
Login to view comments.
Click here to Login
2021